Systemic treatment and new developments in advanced prostate cancer
- 1 October 2001
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 37, 147-157
- https://doi.org/10.1016/s0959-8049(01)80016-2
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- The bicalutamide Early Prostate Cancer Program: DemographyUrologic Oncology: Seminars and Original Investigations, 2001
- Adjuvant and neoadjuvant therapy in prostate cancerSeminars in Oncology, 2001
- COMPLETE ANDROGEN BLOCKADE FOR PROSTATE CANCER: WHAT WENT WRONG?Journal of Urology, 2000
- 4–Year Follow–Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy in T2–3N0M0 Prostate CancerEuropean Urology, 2000
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerNew England Journal of Medicine, 1999
- Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate CancerNew England Journal of Medicine, 1998
- Ketoconazole Retains Activity in Advanced Prostate Cancer Patients with Progression Despite Flutamide WithdrawalJournal of Urology, 1997
- Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide SearchScience, 1996
- Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate CancerJournal of Urology, 1995
- Results of Conservative Management of Clinically Localized Prostate CancerNew England Journal of Medicine, 1994